There are 2789 resources available
1328P - Outcomes from local consolidative therapy and immune checkpoint inhibitors in metastatic non-small cell lung cancer
Presenter: Lingzhi Hong
Session: ePoster Display
1330P - Second-line nintedanib + docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: Updated efficacy and safety results from VARGADO Cohort C
Presenter: Christian Grohé
Session: ePoster Display
1391P - Clinical progress in inoperable or recurrent advanced gastric cancer treatment from 1,004 single institute experiences between 2007 and 2018
Presenter: Izuma Nakayama
Session: ePoster Display
1392P - Submucosal versus subserosal approaches toward optimized indocyanine green tracer-guided lymphadenectomy for gastric cancer: A randomized clinical trial
Presenter: Qi-Yue Chen
Session: ePoster Display
1393P - Phase I/II clinical trial of combination of anti-PD-1 mAb, nivolumab with radiotherapy for unresectable and recurrent gastric cancer who failed to standard chemotherapy
Presenter: Koji Kono
Session: ePoster Display
1394P - Frequentist and Bayesian analysis of second line treatment effectiveness in AGAMENON-SEOM gastric cancer registry
Presenter: Nieves Martinez Lago
Session: ePoster Display
1291P - A phase II study of nivolumab rechallenge therapy in advanced NSCLC patients who responded to prior anti-PD-1/L1 inhibitors: West Japan Oncology Group 9616L
Presenter: Shunsuke Teraoka
Session: ePoster Display